The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Evaluation of Mucogyne® Ovule in Vulvovaginal Dryness Management in Women Treated by Brachytherapy and/or Radiotherapy for Endometrial or Cervical Cancer.
Official Title: Evaluation of Mucogyne® Ovule in Vulvovaginal Dryness Management in Women Treated by Brachytherapy and/or Radiotherapy for Endometrial or Cervical Cancer.
Study ID: NCT04664985
Brief Summary: Randomized, open-label, national (France), multicenter, prospective clinical study, to evaluate the superiority of Mucogyne® ovules over the control group on vaginal health (including hydration) in women treated by brachytherapy and/or radiotherapy for endometrial or cervical cancer.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Chru Besancon - Site 002, Besançon, , France
Leon Berard - Site 007, Lyon, , France
Institut de Cancerologie de Lorraine - Site 004, Nancy, , France
Chu Nantes - Site 003, Nantes, , France
Chu Caremeau - Site 001, Nîmes, , France
Clinique Pasteur - Site 005, Toulouse, , France
Institut Gustave Roussy - Site 006, Villejuif, , France